Single-Dose Empiric Therapy for Gonorrhea and Chlamydia

Primary Recommendation

• The American College of Physicians recommends ceftriaxone 500 mg IM (single dose) PLUS azithromycin 1 g orally (single dose) for empiric treatment when both gonorrhea and chlamydia exposure is suspected 1, 2
• Co-infection rates are extremely high, with 40-50% of gonorrhea patients also having chlamydia, making dual therapy essential 1, 2

Critical Limitation: Not Truly Single-Dose for Chlamydia

• The Centers for Disease Control and Prevention notes that while this regimen uses single doses of each drug, azithromycin 1 g as a single dose is the only true single-dose option for chlamydia coverage 1, 2
• If azithromycin cannot be used, doxycycline 100 mg orally twice daily for 7 days is required for adequate chlamydia treatment, which is NOT a single-dose regimen 1

Alternative Single-Dose Regimens (When Ceftriaxone Unavailable)

• The Infectious Diseases Society of America recommends cefixime 400 mg orally (single dose) PLUS azithromycin 1 g orally (single dose) as an alternative regimen if ceftriaxone is unavailable 1, 2
• This regimen requires mandatory test-of-cure at 1 week due to inferior efficacy compared to ceftriaxone 1, 2

Site-Specific Considerations

• Pharyngeal gonorrhea is significantly more difficult to eradicate than urogenital or anorectal infections, with ceftriaxone having superior efficacy for pharyngeal infections 3, 1, 2
• Spectinomycin has only 52% efficacy for pharyngeal infections and should never be used if pharyngeal exposure is suspected 1, 2

Critical Pitfalls to Avoid

• The World Health Organization advises against using quinolones (ciprofloxacin, ofloxacin) for gonorrhea treatment due to widespread resistance 1, 4, 2
• Azithromycin 1 g alone should not be used for gonorrhea treatment due to insufficient efficacy at only 93% cure rate 1, 2

Special Populations

• In pregnancy, the recommended treatment is ceftriaxone 500 mg IM (single dose) PLUS azithromycin 1 g orally (single dose) 1, 2
• Doxycycline, quinolones, or tetracyclines should never be used in pregnancy 1

Follow-Up Requirements

• Patients treated with the recommended ceftriaxone plus azithromycin regimen do NOT need routine test-of-cure unless symptoms persist 3, 1, 2
• All patients should be retested approximately 3 months after treatment due to high reinfection risk 3, 1

Partner Management

• All sexual partners from the preceding 60 days should be evaluated and treated with the same dual therapy regimen 1, 2
• Patients should avoid sexual intercourse until therapy is completed and both patient and partners are asymptomatic 1, 2

CDC Guidelines for Managing Oropharyngeal Gonorrhea

Ineffective Regimens and Contraindicated Agents

Treatment Recommendations for Specific Populations

Partner Management and Ancillary Screening

Guideline Recommendations for Gonorrhea Treatment in Pregnancy and When Ceftriaxone Is Unavailable

Pregnancy and Breastfeeding

• Quinolones, tetracyclines, and doxycycline should be avoided in pregnant or lactating individuals; ceftriaxone 500 mg IM plus azithromycin 1 g orally remains the recommended regimen. 9

Alternative Oral Regimen When Ceftriaxone Is Unavailable

• The CDC (MMWR) recommends a single oral dose of cefixime 400 mg combined with azithromycin 1 g for the treatment of uncomplicated gonorrhea when injectable ceftriaxone cannot be used. [10][11]

• This cefixime‑based regimen demonstrates slightly lower cure rates (97.4 %) compared with the standard ceftriaxone regimen (98.9 %). [10][11]